Published on 6 Sep 2023 on Exec Edge via Yahoo Finance
Eterna Therapeutics Teams with Lineage Cell on Transplant Therapies
By Daniella Parra
Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therapeutics, Inc. to develop stem cell lines for central nervous system diseases, the company said.